EMR
77
-2
LRCX
46
-2
DLTR
40
4
PNR
74
5
AA
38
-2
TXN
49
-6
MAT
38
-3
TAP
64
4
KLAC
45
-4
REGN
42
-2
PWR
71
-3
NWSA
71
-2
MMM
42
5
MLM
57
-3
CAH
60
2
LOW
58
2
ALLE
41
-7
LNC
45
-4
IFF
53
2
VZ
42
3
EMR
77
-2
LRCX
46
-2
DLTR
40
4
PNR
74
5
AA
38
-2
TXN
49
-6
MAT
38
-3
TAP
64
4
KLAC
45
-4
REGN
42
-2
PWR
71
-3
NWSA
71
-2
MMM
42
5
MLM
57
-3
CAH
60
2
LOW
58
2
ALLE
41
-7
LNC
45
-4
IFF
53
2
VZ
42
3
Financhill
Back

Charles River Laboratories International Stock Predictions

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
49

CRL
Charles River Laboratories International

Last Price:
199.79
Seasonality Move:
8.38%

7 Day Trial

ALL ACCESS PASS

$ 7

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.

Charles River Laboratories International Stock Forecast

  • Over the next 52 weeks, Charles River Laboratories International has on average historically risen by 14.6% based on the past 24 years of stock performance.
  • Charles River Laboratories International has risen higher in 16 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Charles River Laboratories International Stock Undervalued?
    The current Charles River Laboratories International [CRL] share price is $206.54. The Score for CRL is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • CRL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Charles River Laboratories International Stock Go Up Next Year?

  • Over the next 52 weeks, Charles River Laboratories International has on average historically risen by 14.6% based on the past 24 years of stock performance.

Charles River Laboratories International Stock Rating

Sell
49
Charles River Laboratories International (CRL) is a Sell

Is Charles River Laboratories International overpriced?

  • Charles River Laboratories International has risen higher in 16 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Charles River Laboratories International Stock Price History

Is CRL stock going to rise?

  • The current trend is moderately bullish and CRL is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYSE
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
criver.com

52-Week Data

52-Week High:
275.00
52-Week Low:
174.92

Prediction Charts

Market Cap:
10.56B
Price in USD:
206.54
Volume:
976.71K
Beta:
0.97

Technical Analysis

SMA50:
195.03
SMA100:
203.31
SMA200:
220.11
52-Wk Change:
21.47%

Stock Predictions

  • Is Charles River Laboratories International stock public?
    Yes, Charles River Laboratories International is a publicly traded company.
  • What is the Charles River Laboratories International stock quote today?
    The Charles River Laboratories International stock price is 206.54 USD today.
  • How to buy Charles River Laboratories International stock online?
    You can buy Charles River Laboratories International shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-25 184.15 182.12 184.55 181.53
Oct-28 185.21 186.52 188.00 184.26
Oct-29 186.00 184.00 186.46 182.22
Oct-30 181.19 181.39 186.37 180.24
Oct-31 178.91 178.58 181.23 176.48
Nov-1 180.40 180.96 184.04 179.46
Nov-4 179.93 182.48 185.86 179.93
Nov-5 180.89 188.68 189.18 180.50
Nov-6 228.99 214.20 230.02 208.55
Nov-7 215.75 210.29 217.60 209.97
Nov-8 210.29 215.39 216.15 208.52
Nov-11 217.45 220.69 222.10 217.00
Nov-12 218.25 215.94 221.60 213.35
Nov-13 217.75 206.54 217.75 205.55

Charles River Laboratories International Earnings

Charles River Laboratories International Earnings Report: Per Share Charles River Laboratories International Earnings Q1 Q2 Q3 and Q4 last year and next year.

Charles River Laboratories International Forecast Revenue Growth

Charles River Laboratories International Stock Analysis: Historical quarterly revenues per share for Charles River Laboratories International and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $0.17 per share.

* Charles River Laboratories International stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.